DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 778 filers reported holding DANAHER CORPORATION in Q2 2013. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,822,498 | +8.1% | 15,299 | +8.1% | 0.09% | +3.3% |
Q1 2024 | $3,535,066 | +19.6% | 14,156 | +10.8% | 0.09% | +8.4% |
Q4 2023 | $2,954,702 | +4.8% | 12,772 | +12.4% | 0.08% | -9.8% |
Q3 2023 | $2,819,686 | +13.1% | 11,365 | +9.4% | 0.09% | +16.5% |
Q2 2023 | $2,492,668 | -9.5% | 10,386 | -4.9% | 0.08% | -14.1% |
Q1 2023 | $2,753,566 | -9.5% | 10,925 | -4.7% | 0.09% | -17.1% |
Q4 2022 | $3,043,071 | -34.2% | 11,465 | -37.1% | 0.11% | +18.1% |
Q2 2022 | $4,624,000 | +75.2% | 18,238 | +102.7% | 0.09% | +3.3% |
Q1 2022 | $2,639,000 | -10.2% | 8,997 | +0.7% | 0.09% | -1.1% |
Q4 2021 | $2,938,000 | +36.5% | 8,931 | -10.6% | 0.09% | -11.5% |
Q3 2021 | $2,152,000 | +46.3% | 9,994 | +82.3% | 0.10% | +76.3% |
Q2 2021 | $1,471,000 | -37.8% | 5,481 | -47.8% | 0.06% | -57.2% |
Q1 2021 | $2,364,000 | +4.3% | 10,502 | +2.9% | 0.14% | +0.7% |
Q4 2020 | $2,267,000 | +12.1% | 10,207 | +8.6% | 0.14% | -18.5% |
Q3 2020 | $2,023,000 | +23.5% | 9,396 | +1.4% | 0.17% | +14.3% |
Q2 2020 | $1,638,000 | +35.9% | 9,265 | +6.5% | 0.15% | +11.4% |
Q1 2020 | $1,205,000 | -9.4% | 8,700 | +0.4% | 0.13% | +21.1% |
Q4 2019 | $1,330,000 | +6.1% | 8,663 | -0.1% | 0.11% | +2.8% |
Q3 2019 | $1,253,000 | +1.1% | 8,676 | +0.1% | 0.11% | +2.9% |
Q2 2019 | $1,239,000 | +10.8% | 8,668 | +2.3% | 0.10% | +5.1% |
Q1 2019 | $1,118,000 | +16.5% | 8,469 | -9.0% | 0.10% | +5.4% |
Q4 2018 | $960,000 | -7.0% | 9,310 | -1.9% | 0.09% | 0.0% |
Q3 2018 | $1,032,000 | +4.0% | 9,493 | -5.6% | 0.09% | -7.0% |
Q2 2018 | $992,000 | +2.1% | 10,057 | +1.3% | 0.10% | -4.8% |
Q1 2018 | $972,000 | +146.1% | 9,926 | +133.0% | 0.10% | +144.2% |
Q4 2017 | $395,000 | -2.2% | 4,260 | -9.6% | 0.04% | -8.5% |
Q3 2017 | $404,000 | -10.2% | 4,711 | -11.7% | 0.05% | -19.0% |
Q2 2017 | $450,000 | +2.3% | 5,335 | +3.8% | 0.06% | -4.9% |
Q1 2017 | $440,000 | -55.0% | 5,139 | -59.1% | 0.06% | -61.6% |
Q4 2016 | $978,000 | -35.8% | 12,563 | -35.3% | 0.16% | -41.1% |
Q3 2016 | $1,523,000 | -21.7% | 19,427 | +0.9% | 0.27% | -21.7% |
Q2 2016 | $1,945,000 | +18.5% | 19,256 | +11.3% | 0.34% | +15.4% |
Q1 2016 | $1,641,000 | +3.2% | 17,296 | +1.0% | 0.30% | -13.3% |
Q4 2015 | $1,590,000 | +15.6% | 17,120 | +6.0% | 0.34% | -6.2% |
Q3 2015 | $1,376,000 | +1.7% | 16,149 | +2.2% | 0.37% | +4.0% |
Q2 2015 | $1,353,000 | +4.6% | 15,805 | +3.7% | 0.35% | -0.8% |
Q1 2015 | $1,294,000 | +217.2% | 15,241 | +188.2% | 0.36% | +172.5% |
Q4 2013 | $408,000 | +11.2% | 5,288 | 0.0% | 0.13% | +8.3% |
Q3 2013 | $367,000 | +10.2% | 5,288 | +0.4% | 0.12% | +7.1% |
Q2 2013 | $333,000 | – | 5,268 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |